Development of a medication experience scale for patients with chronic disease in primary care facilities

Jiaxian Shao , Haihong Cao , Zhihong Sun , Xiaona Li , Min Gao , Ziyuan Li , Yongli Shi , Ping Dong , Wenqiang Yin , Zhongming Chen

Chinese General Practice Journal ›› 2025, Vol. 2 ›› Issue (1) : 100044

PDF (941KB)
Chinese General Practice Journal ›› 2025, Vol. 2 ›› Issue (1) :100044 DOI: 10.1016/j.cgpj.2025.100044
research-article
Development of a medication experience scale for patients with chronic disease in primary care facilities
Author information +
History +
PDF (941KB)

Abstract

Background: Understanding patients' medication experience is crucial for improving adherence, health outcomes, and medical safety. Currently, there is a lack of measurement tools for the medication experience of patients with chronic diseases in primary care facilities in China, which seriously restricts the research and practice of pharmaceutical service and management in primary care facilities.

Objective: This study aims to develop the Medication Experience Scale For Patients with Chronic Disease in Primary Care Facilities tailored to China's chronic disease management practices. The scale is intended to support research and practice in medication management for chronic disease patients.

Methods: A preliminary item pool for the scale was constructed through literature review, semi-structured interviews, and focus group discussions. The Delphi Method was employed to consult experts and refine the scale. A pilot survey was conducted with 313 chronic disease patients from primary care facilities, selected via random sampling. The reliability and validity of the scale were tested, and iterative adjustments were made to optimize its content.

Results: The finalized scale consists of 3 primary dimensions, 7 secondary dimensions, and 28 measurement items. Item analysis yielded P-values < 0.05. The Cronbach's α coefficients for the overall scale and all dimensions exceeded 0.8, with split-half reliabilities above 0.7 and intra-class correlation coefficients above 0.8, indicating high reliability. Post-rotation factor loadings for all items exceeded 0.5. The confirmatory factor analysis demonstrated excellent model fit: CMIN/DF = 1.485, GFI = 0.902, RMSEA = 0.039, RMR = 0.03, CFI = 0.981, NFI = 0.945, IFI = 0.981. Composite reliability values were above 0.7, and average variance extracted values exceeded 0.5, demonstrating strong validity.

Conclusion: The Medication Experience Scale For Patients with Chronic Disease in Primary Care Facilities developed in this study exhibits better reliability and validity. Its adaptability to local contexts make it a suitable tool for investigating the medication experiences of chronic disease patients in primary care facilities.

Keywords

Chronically disease / Medication experience / Patients experience / Scale development

Cite this article

Download citation ▾
Jiaxian Shao, Haihong Cao, Zhihong Sun, Xiaona Li, Min Gao, Ziyuan Li, Yongli Shi, Ping Dong, Wenqiang Yin, Zhongming Chen. Development of a medication experience scale for patients with chronic disease in primary care facilities. Chinese General Practice Journal, 2025, 2(1): 100044 DOI:10.1016/j.cgpj.2025.100044

登录浏览全文

4963

注册一个新账户 忘记密码

Declarations

Not applicable.

Authors' contributions

Conceptualization, S.J. and C.Z.; Methodology, S.J., C.Z., L.X., G.M., S.Y. and D.P.; Data curation, S.J., C.Z., L.X., G.M., S.Y. and D.P.; Formal analysis, C.H., S.Z. and Y.W.; Funding acquisition, not applicable; Project administration, not applicable; Resources, not applicable; Supervision, C.Z.; Validation, C.Z.; Writingoriginal draft, S.J.; Writingreview and editing, C.Z. All authors have read and agreed to the published version of the manuscript.

Ethical approval and consent to participate

Ethical approval and consent to participate: The study received approval from Second Medical University of Shandong (No. 2021YX-066).

Consent for publication

Not applicable.

Availability of data and materials

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Funding

Not applicable.

Acknowledgements

Not applicable.

Authors' other information

Not applicable.

Supplementary materials

Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.cgpj.2025.100044.

References

[1]

State Council. Opinions on implementing the Healthy China Action. (Chinese). 2019 Jul 15 [cited 2024 Jul 10]. Available from: http://www.gov.cn/zhengce/content/2019-07/15/content_5409492.htm

[2]

State Council Information Office. Transcript of the press conference on the Report on Nutrition and Chronic Disease Status of Chinese Residents (2020). (Chinese). 2020 Dec 23 [cited 2024 Jul 10]. Available from: http://www.scio.gov.cn/xwfbh/xwbfbh/wqfbh/42311/44583/wz44585/Document/1695276/1695276.htm

[3]

National Health Commission of the People’s Republic of China. China Health Statistics Yearbook 2020. (Chinese). 2021.

[4]

Zhongming C, Lifang Z, Haiyuan L, et al. Effect of healthcare system reforms on job satisfaction among village clinic doctors in China. Hum Resour Health. 2021; 19(1):109.

[5]

Ge HT. Study On the Current Status and Influencing Factors of Medical Experience of Elderly Outpatients in General Hospitals. (Chinese). Shandong University; 2023.

[6]

Gao M, Li XN, Shi YL, et al. Analysis of the impact of medication experience on medication adherence in elderly patients with chronic diseases. (Chinese). Chin Gen Pract. 2024:1-6. [cited 2024 Jul 23]. Available from: http://kns.cnki.net/kcms/detail/13.1222.R.20240716.1703.004.html.

[7]

Zhang JJ. Research on Medical Service Management Based on Patient Experience and Patient participation. (Chinese). Beijing Institute of Technology; 2021.

[8]

Shoemaker SJ, Ramalho de Oliveira D, Alves M, et al. The medication experience: preliminary evidence of its value for patient education and counseling on chronic medications. Patient Educ Couns. 2011; 83(3):443-450 Jun.

[9]

Glinert LH. Communicative and discursive perspectives on the medication experience. Pharmacy (Basel). 2021; 9(1):42 Feb 17.

[10]

Bzowyckyj AS, Begert JE. Diabetes, therapeutic inertia, and patients’ medication experience. Diabetes Spectr. 2020; 33(1):31-37 Feb.

[11]

Witry MJ, Fadare OO, Pham K. Evaluation of a Revised Home Medication Experience Questionnaire (HOME-Qv2). Pharmacy (Basel). 2020; 8(3):169 Sep 11.

[12]

Tian QX, Yu LJ. Reliability and validity testing of the Chinese version of the Medication Adherence Scale for bronchial asthma. (Chinese). Chin J Nurs. 2014; 49(5):621-624.

[13]

Zhang R, Tian QX, Yu LJ. Study on adherence to inhaled corticosteroids treatment in patients with bronchial asthma. (Chinese). Chin J Nurs. 2015; 50(1):42-47.

[14]

Shen ZY, Ding SQ, Zhong ZQ, et al. Evaluation of the reliability and validity of the Chinese version of the Medication Satisfaction Questionnaire version 2 in hypertensive patients. (Chinese). Chin Ment Health J. 2021; 35(4):277-283.

[15]

Yi YL. Translation and Preliminary Application of the Anticoagulant Treatment Satisfaction Scale. (Chinese). Hengyang: University of South China; 2021.

[16]

Yi YL, Bai XL, Xie GH, et al. Factors influencing anticoagulant treatment satisfaction in patients after heart mechanical valve replacement surgery. (Chinese). Gen Nurs. 2022; 20(1):1-6.

[17]

Dong XF, Liu YJ, Wang AX. Translation, reliability, and validity testing of the Self-Efficacy for Appropriate Medication Use Scale. (Chinese). J Nurs Sci. 2015; 30(11):47-49.

[18]

Wang CK, Hu ZF, Liu Y. A study on the reliability and validity of the General Self-Efficacy Scale. (Chinese). Appl Psychol. 2001(1):37-40.

[19]

Zhao YN, Jing LW, Zhang P, et al. Relationship between efficacy levels and health behavior factors in the hypertensive population. (Chinese). Chin J Public Health. 2014; 30(7):902-905.

[20]

Shang YB. Study On Factors Related to Medication Adherence of Immunosuppressive Drugs in Kidney Transplant recipients. (Chinese). Beijing: Beijing University of Chinese Medicine; 2017.

[21]

Sun P. The Impact of Nursing Interventions on Self-Efficacy and Adherence Behaviors in Community Patients with Primary hypertension. (Chinese). Peking Union Medical College; 2006.

[22]

Zhang X, Du LP, Li SY, et al. Translation and preliminary application of the 2011 version of the American Medication Safety Self-Assessment Scale. (Chinese). Chin J Hosp Pharm. 2017; 37(21):2109-2112.

[23]

Zhang XY, Wang JR, Huang LT, et al. Development of a scale for assessing patients’ and families’ awareness and experience of hospital culture. (Chinese). Chin Hosp Manag. 2024; 44(6):20-24.

[24]

Liu GZ, Tang JJ, Zhang AQ, et al. Development and reliability/validity testing of a patient safety culture evaluation scale. (Chinese). Chin Health Qual Manag. 2024; 31(4):68-72 77.

[25]

Yue SP, Li HY, Wang Y, et al. Development of the Elderly Dementia and Disability Scale: Application of statistical methods in item selection. (Chinese). Chin J Geriatr. 2020; 40(18):4009-4011.

[26]

Zou J, Zhang HY, Chen S, et al. Development and reliability/validity testing of a triage assessment scale for emergency trauma patients. (Chinese). Med Inf. 2024; 37(9):60-64.

[27]

Gu SY, Wang XY, Zhang N, et al. Development and reliability/validity testing of a self-management cognition scale for patients with type 2 diabetes. (Chinese). J Nurs Sci. 2024; 39(8):29-32 38.

[28]

Cao WP, Li GR, Guo Y, et al. Development and reliability/validity study of a readiness for discharge scale for neonates. (Chinese). Chin J Health Stat. 2024; 41(2):291-295.

PDF (941KB)

68

Accesses

0

Citation

Detail

Sections
Recommended

/